The global digital polymerase chain reaction market generated $508.8 million in 2020 and is projected to reach $1,139.9 million by 2028, growing at a CAGR of 9.1% from 2021 to 2028.
Digital polymerase chain reaction (dPCR) is a new approach for the detection and quantification of nucleic acids that provides a sensitive and reproducible way to measure the amount of DNA or RNA present in a sample. dPCR exhibits high potential in the research (basic research and applied research), clinical diagnostics, forensics, and other similar areas. dPCR systems are useful for copy number variation, rare sequence detection, mutation detection, miRNA analysis, gene expression analysis, and next-generation sequencing sample quantification.
The global digital polymerase chain reaction market is expected to register substantial growth in the near future, owing to the rise in the prevalence of infectious diseases and an increase in awareness & acceptance of personalized medicines. In addition, advancements in the technique are anticipated to boost the market growth during the forecast period.
However, the high cost of dPCR devices and reimbursement issues are the factors anticipated to hamper market growth during the forecast period. Conversely, an increase in funding for R&D activities is expected to offer remunerative opportunities for market players. The digital polymerase chain reaction market is segmented into technology, product type, application, end user, and region. By technology, the market is categorized into droplet digital PCR (ddPCR) and BEAMing digital PCR.
By technology, the market is bifurcated into droplet digital PCR (ddPCR), chip based digital PCR and BEAMing digital PCR. Depending on product type, it is fragmented into digital PCR systems, consumables & reagents, and software & services. On the basis of application, it is segregated into research, clinical diagnostics, and forensic & others. As per end user, it is differentiated into pharmaceuticals & biotechnology industries, clinical diagnostic laboratories, and universities & other organizations. Region wise, it is analyzed across North America (U.S., Canada, Mexico) Europe (Germany, France, UK, Italy, Spain, Rest of Europe) Asia-Pacific (Japan, China, Australia, India, South Korea, Taiwan and rest of Asia-Pacific) and LAMEA (Brazil, Saudi Arabia, South Africa, and Rest of LAMEA).
This report entails a detailed quantitative analysis of the current market trends from 2020 to 2028 to identify prevailing opportunities along with a strategic assessment of the global digital PCR market.
Market size and estimations are based on a comprehensive analysis of end users, developments, and services in the industry.
An in-depth analysis based on region assists to understand the regional market and facilitates strategic business planning.
Developmental strategies adopted by the key market players are enlisted to understand the competitive scenario of the market.
Key Topics Covered:
CHAPTER 1: INTRODUCTION
CHAPTER 2: EXECUTIVE SUMMARY
CHAPTER 3: MARKET OVERVIEW 3.1. Market definition and scope 3.2. Key findings 3.2.1. Top investment pockets 3.3. Porter's five forces analysis 3.4. Top player positioning, 2020 3.5. Market dynamics 3.5.1. Drivers 18.104.22.168. Rise in prevalence of infectious diseases and cancer 22.214.171.124. Increase in awareness and acceptance of personalized medicines 126.96.36.199. Technological advancements 3.5.2. Restraints 188.8.131.52. High cost of dPCR devices 184.108.40.206. Reimbursement issues 3.5.3. Opportunity 220.127.116.11. Increase in funding for R&D activities 3.6. NGS technology Impact on Digital PCR Market 3.7. Impact analysis of COVID-19 on the digital PCR market
CHAPTER 4: DIGITAL POLYMERASE CHAIN REACTION MARKET, BY TECHNOLOGY 4.1. Overview 4.1.1. Market size and forecast 4.1.2. Market size and forecast for PCR Market, 2017-2023 4.2. Droplet digital PCR 4.2.1. Key market trends, growth factors, and opportunities 4.2.2. Market size and forecast 4.2.3. Market analysis, by country 4.3. Chip based digital PCR 4.3.1. Key market trends, growth factors, and opportunities 4.3.2. Market size and forecast 4.3.3. Market analysis, by country 4.4. BEAMing dPCR 4.4.1. Key market trends, growth factors, and opportunities 4.4.2. Market size and forecast 4.4.3. Market analysis, by country
CHAPTER 5: DIGITAL POLYMERASE CHAIN REACTION MARKET, BY PRODUCT TYPE 5.1. Overview 5.1.1. Market size and forecast 5.2. Consumables & reagents 5.2.1. Market size and forecast 5.2.2. Market analysis, by country 5.3. Digital PCR systems 5.3.1. Market size and forecast 5.3.2. Market analysis, by country 5.4. Software & services 5.4.1. Market size and forecast 5.4.2. Market analysis, by country
CHAPTER 6: DIGITAL POLYMERASE CHAIN REACTION MARKET, BY APPLICATION 6.1. Overview 6.1.1. Market size and forecast 6.2. Research 6.2.1. Market size and forecast 6.2.2. Market analysis, by country 6.3. Clinical diagnostics 6.3.1. Market size and forecast 6.3.2. Market analysis, by country 6.4. Forensic & others 6.4.1. Market size and forecast 6.4.2. Market analysis, by country
CHAPTER 7: DIGITAL POLYMERASE CHAIN REACTION MARKET, BY END USER 7.1. Overview 7.1.1. Market size and forecast 7.2. Clinical diagnostic laboratories 7.2.1. Market size and forecast 7.2.2. Market analysis, by country 7.3. Pharmaceuticals & biotechnology industries 7.3.1. Market size and forecast 7.3.2. Market analysis, by country 7.4. Universities & other organizations 7.4.1. Market size and forecast 7.4.2. Market analysis, by country
CHAPTER 8: DIGITAL POLYMERASE CHAIN REACTION MARKET, BY REGION
CHAPTER 9: COMPANY PROFILES 9.1. 4BASEBIO AG 9.1.1. Company overview 9.1.2. Company snapshot 9.1.3. Operating business segments 9.1.4. Product portfolio 9.1.5. Business Performance 9.2. BIO-RAD LABORATORIES, INC. 9.2.1. Company overview 9.2.2. Company snapshot 9.2.3. Operating business segments 9.2.4. Product portfolio 9.2.5. Business performance 9.2.6. Key strategic moves and developments 9.3. COMBINATI, INC. 9.3.1. Company overview 9.3.2. Company snapshot 9.3.3. Operating business segments 9.3.4. Product portfolio 9.3.5. Key strategic moves and developments 9.4. FLUIDIGM CORPORATION 9.4.1. Company overview 9.4.2. Company snapshot 9.4.3. Operating business segments 9.4.4. Product portfolio 9.4.5. Business performance 9.5. JN MEDSYS 9.5.1. Company overview 9.5.2. Company snapshot 9.5.3. Product portfolio 9.5.4. Key strategic moves and developments 9.6. MERCK KGAA 9.6.1. Company overview 9.6.2. Company snapshot 9.6.3. Operating business segments 9.6.4. Product portfolio 9.6.5. Business performance 9.6.6. Key strategic moves and developments 9.7. QIAGEN N. V. 9.7.1. Company overview 9.7.2. Company snapshot 9.7.3. Operating business segment 9.7.4. Product portfolio 9.7.5. Business performance 9.7.6. Key strategic moves and developments 9.8. SYSMEX CORPORATION 9.8.1. Company overview 9.8.2. Company snapshot 9.8.3. Operating business segments 9.8.4. Product portfolio 9.8.5. Business performance 9.9. STILLA TECHNOLOGIES 9.9.1. Company overview 9.9.2. Company snapshot 9.9.3. Product portfolio 9.9.4. Key strategic moves and developments 9.10. THERMO FISHER SCIENTIFIC, INC. 9.10.1. Company overview 9.10.2. Company snapshot 9.10.3. Operating business segments 9.10.4. Product portfolio 9.10.5. Business performance